[Significance of the dose of josamycin in the treatment of chlamydia infected pregnant patients].
Erythromycin and josamycin are the antibiotics of choice in the treatment of pregnant women with Chlamydia infection. On the basis of differing recommendations in the literature regarding treatment period and dosage, two groups of pregnant women were treated with josamycin according to different dosage schedules: Group A: 170 patients treated with 2 x 500 mg daily for 12 days. Group B: 120 patients treated with 3 x 500 mg daily for 8 days. The diagnosis was confirmed by immunofluorescence with monoclonal antibodies. Non-responding patients were treated again with a similar dose. 17% of the patients in group A and 9.1% in group B were still positive for Chlamydia after the first course of treatment. After a second course, 13.6% of group A and none of group B showed positive controls. Failures of therapy after the first treatment course can be attributed to errors in dosage or re-infection, whereas failures after the second course must be due to bad compliance. Our results suggest that pregnant women with Chlamydia infection are most efficiently treated with high dosages of josamycin over a short period of time.
Söltz-Szöts
J
J
Ludwig Boltzmann-Institut zur Erforschung infektiöser venero-dermatolog. Erkrankungen, Wien.
Schneider
S
S
Niebauer
B
B
Knobler
R M
RM
Lindmaier
A
A
D002690:Chlamydia Infections / Q000188:drug therapy*; D002692:Chlamydia trachomatis / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D007933:Leucomycins / Q000008:administration & dosage*; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy*; D002575:Uterine Cervicitis / Q000188:drug therapy*; D014626:Vaginal Smears
D007933:Leucomycins
Bedeutung der Dosierung von Josamycin bei der Behandlung von Chlamydien-infizierten Schwangeren.